S1P receptors modulators

Details for Australian Patent Application No. 2009304596 (hide)

Owner Akaal Pharma Pty Ltd

Inventors Gill, Gurmit S.; Grobelny, Damian W.

Agent Watermark

Pub. Number AU-A-2009304596

PCT Pub. Number WO2010/042998

Priority 2009902561 04.06.09 AU; 2008905356 17.10.08 AU

Filing date 16 October 2009

Wipo publication date 22 April 2010

International Classifications

C07C 215/68 (2006.01) Compounds containing amino and hydroxy groups bound to the same carbon skeleton

A61K 31/136 (2006.01) - having the amino group directly attached to the aromatic ring, e.g. benzeneamine

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/4045 (2006.01)

A61K 31/4245 (2006.01) - Oxadiazoles

A61K 31/47 (2006.01) - Quinolines

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

C07C 215/10 (2006.01) Compounds containing amino and hydroxy groups bound to the same carbon skeleton

C07C 215/18 (2006.01) Compounds containing amino and hydroxy groups bound to the same carbon skeleton

C07C 215/52 (2006.01) Compounds containing amino and hydroxy groups bound to the same carbon skeleton

C07C 217/60 (2006.01) Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton

C07C 217/62 (2006.01) Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton

C07C 217/80 (2006.01) Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton

C07C 225/16 (2006.01) Compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly-bound oxygen atoms not being part of a CHO group, e.g. amino ketones

C07D 209/08 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/12 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/38 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/44 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 215/06 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 215/20 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 217/04 Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

Event Publications

2 June 2011 PCT application entered the National Phase

  PCT publication WO2010/042998 Priority application(s): WO2010/042998

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009304598-S1P receptors modulators and their use thereof

2009304595-Compositions and methods for treatment of kidney disorders